ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
5,994.29
0.22%
US Tech 100
21,234.40
0.35%
Dow Jones
42,305.27
0.32%
Brent Oil
75.695
-2.37%
Bitcoin
105,569.46
0.83%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. InflaRx NV (IFRX) Quote

InflaRx NV

InflaRx NV (IFRX)

NASDAQ
0.7988
0.0008
( 0.10% )
Updated: 10:01:25
15 min delayed - Upgrade to Realtime

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.7988
Bid
0.7715
Ask
0.80
Volume
45,162
0.7716 Day's Range 0.809
0.7113 52 Week Range 2.815
Market Cap
47.41M
Previous Close
0.798
Open
0.80
Last Trade
100
@
0.7988
Last Trade Time
10:01:25
Financial Volume
$ 36,307
VWAP
0.803918
Average Volume (3m)
491,106
Shares Outstanding
59,351,710
Dividend Yield
-
PE Ratio
-1.03
Earnings Per Share (EPS)
-0.78
Revenue
166k
Net Profit
-46.06M

About InflaRx NV

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator in... InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.inflarx.de
Headquarters
Jena, Deu
Founded
-
InflaRx NV is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IFRX. The last closing price for InflaRx NV was $0.80. Over the last year, InflaRx NV shares have traded in a share price range of $ 0.7113 to $ 2.815.

InflaRx NV currently has 59,351,710 shares outstanding. The market capitalization of InflaRx NV is $47.36 million. InflaRx NV has a price to earnings ratio (PE ratio) of -1.03.

Ask ADVFN Intelligence (AI)

IFRX Latest News

More News

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
May 07 2025
IFRX (0.10%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
April 24 2025
IFRX (0.10%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
April 03 2025
IFRX (0.10%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
March 20 2025
IFRX (0.10%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.00180.2258469259720.7970.83180.754396300.78418964CS
4-0.9812-55.12359550561.781.90.71139647460.8028808CS
12-0.4312-35.05691056911.231.920.71134911061.0092894CS
26-1.2812-61.59615384622.082.770.71134187951.38388872CS
52-0.6312-44.13986013991.432.8150.71132857671.54961503CS
156-0.4212-34.52459016391.227.24990.71134494083.4862854CS
260-4.4512-84.78476190485.257.24990.71135358573.75751316CS

IFRX - Frequently Asked Questions (FAQ)

What is the current InflaRx NV share price?
The current share price of InflaRx NV is $ 0.7988
How many InflaRx NV shares are in issue?
InflaRx NV has 59,351,710 shares in issue
What is the market cap of InflaRx NV?
The market capitalisation of InflaRx NV is USD 47.36M
What is the 1 year trading range for InflaRx NV share price?
InflaRx NV has traded in the range of $ 0.7113 to $ 2.815 during the past year
What is the PE ratio of InflaRx NV?
The price to earnings ratio of InflaRx NV is -1.03
What is the cash to sales ratio of InflaRx NV?
The cash to sales ratio of InflaRx NV is 285.71
What is the reporting currency for InflaRx NV?
InflaRx NV reports financial results in EUR
What is the latest annual turnover for InflaRx NV?
The latest annual turnover of InflaRx NV is EUR 166k
What is the latest annual profit for InflaRx NV?
The latest annual profit of InflaRx NV is EUR -46.06M
What is the registered address of InflaRx NV?
The registered address for InflaRx NV is WINZERLAER STRABE 2, JENA, 07745
What is the InflaRx NV website address?
The website address for InflaRx NV is www.inflarx.de
Which industry sector does InflaRx NV operate in?
InflaRx NV operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WHLRWheeler Real Estate Investment Trust Inc
$ 9.2499
(170.46%)
28.34M
DFLIDragonfly Energy Holdings Corporation
$ 0.3604
(65.32%)
203.22M
LUCYInnovative Eyewear Inc
$ 3.57
(56.58%)
17.3M
SRMSRM Entertainment Inc
$ 11.4189
(39.25%)
12.43M
GRRRGorilla Technology Group Inc
$ 25.73
(36.79%)
4.1M
NWGLNature Wood Group Ltd
$ 2.304
(-59.08%)
1.24M
MBRXMoleculin Biotech Inc
$ 0.303
(-48.03%)
4.58M
RGCRegencell Bioscience Holdings Ltd
$ 39.00
(-38.44%)
527.5k
OPOceanPal Inc
$ 1.5204
(-30.89%)
610.78k
RBNERobin Energy Ltd
$ 6.06
(-30.58%)
2.07M
DFLIDragonfly Energy Holdings Corporation
$ 0.3604
(65.32%)
203.22M
HCTIHealthcare Triangle Inc
$ 0.0289
(9.06%)
170.87M
PCSAProcessa Pharmaceuticals Inc
$ 0.2769
(14.42%)
72.76M
WLGSWang and Lee Group Inc
$ 0.0573
(-1.21%)
63.52M
GNLNGreenlane Holdings Inc
$ 0.01
(-3.38%)
62.85M

IFRX Discussion

View Posts
0210 0210 2 weeks ago
11 yrs. I-hub absence, how's C3P0?...kewl IFRx DD, lol. 😉😂🤣
👍️0
Monksdream Monksdream 1 month ago
IFRX, under $2
👍️0
glenn1919 glenn1919 2 months ago
IFRX...............................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783
👍️ 1
RTWODTWO RTWODTWO 2 months ago
InflaRx is entering a critical phase with several upcoming catalysts:

Phase 3 interim results for vilobelimab in Pyoderma Gangrenosum (PG) are expected shortly. The program already has both Fast Track and Orphan Drug Designation from the FDA, which could enable accelerated approval if the data are strong.

Phase 2a results for INF904 in Hidradenitis Suppurativa (HS) and Chronic Spontaneous Urticaria (CSU) are anticipated this summer. Both indications target large unmet medical needs and multi-billion-dollar markets.

Preclinical data for INF904 showed superior efficacy compared to Avacopan, which was acquired by Amgen for $3.7B.

InflaRx maintains a cash position of approximately $70M, suggesting the company is fully funded through these major milestones.

Guggenheim Securities has issued a $10 price target for IFRX, representing significant upside potential from current levels.

With multiple important readouts expected this year, IFRX could attract substantial attention if results are positive.

DYOR (Do Your Own Research)
👍️ 1
Monksdream Monksdream 2 months ago
IFRX, under $2
👍️ 1
Monksdream Monksdream 2 months ago
IFRX, under $2
👍️ 1
glenn1919 glenn1919 6 months ago
ifrx...................................https://stockcharts.com/h-sc/ui?s=ifrx&p=W&b=5&g=0&id=p86431144783
👍️ 1
glenn1919 glenn1919 6 months ago
IFRX.................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 6 months ago
IFRX..............................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 7 months ago
IFRX.........................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 7 months ago
IFRX.............................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783
👍️0
glenn1919 glenn1919 7 months ago
IFRX....................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783
👍️0
ralfito ralfito 7 months ago
Is it just the strong financial reports or is there some other news you know of?
Thanks!
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
IFRX READY TO RUMBLE IN THE JUNGLE 2.9 TOP OF WEEKLY PLAY
👍️0
glenn1919 glenn1919 7 months ago
IFRX.............................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783
👍️0
ralfito ralfito 7 months ago
anyone know why its launching?
👍️0
TrendTrade2016 TrendTrade2016 7 months ago
IFRX TAKING OFF
👍️0
glenn1919 glenn1919 7 months ago
IFRX.......................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 11 months ago
IFRX 10Q due AUGUST5
👍️0
Monksdream Monksdream 11 months ago
IFRX under $2
👍️0
Monksdream Monksdream 11 months ago
IFRX under $2
👍️0
glenn1919 glenn1919 1 year ago
IFRX..................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783
👍️0
ralfito ralfito 1 year ago
What is up with IFRX? Seems to be teetering. Numbers look good, except for Forward EPS.
👍️0
glenn1919 glenn1919 1 year ago
IFRX...............................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 year ago
IFRX under $2
👍️0
Monksdream Monksdream 1 year ago
IFRX under $2
👍️0
glenn1919 glenn1919 1 year ago
IFRX................................https://stockcharts.com/h-sc/ui?s=IFRX&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 1 year ago
IFRX under $2
👍️0
Monksdream Monksdream 2 years ago
IFRX new 52 week low
👍️0
TheFinalCD TheFinalCD 2 years ago
https://finviz.com/quote.ashx?t=IFRX&ty=c&ta=1&p=d

does have a REGISTERED SHELF OFFERING

https://dilutiontracker.com/app/search/IFRX?a=dbb88c

Apr-05-23 Upgrade Guggenheim Neutral ? Buy $8
👍️0
enthalpy enthalpy 2 years ago
True waiting on that skin cancer p2 data release or EUA sales update.
👍️0
peterus peterus 2 years ago
going the wronge way
👍️0
peterus peterus 2 years ago
yup $10+ coming
👍️0
enthalpy enthalpy 2 years ago
I added more and its a decent position. I think we have a shot at 10 to 15 short term. Friday looked promising. Hopefully we get a second wave to start in 2 weeks.
👍️0
peterus peterus 2 years ago
you still in ????
im still holding 4s
👍️0
Gator44 Gator44 2 years ago
Closing of offering, here comes first stop $6.25
👍️0
frans frans 2 years ago
IFRX should go slowly 5$ +
👍️0
frans frans 2 years ago
IFRX 4.2 now slowly on the move
👍️0
frans frans 2 years ago
in here at 4.10
👍️0
the_stockoracle the_stockoracle 2 years ago
Still in downtrend and they will keep diluting
👍️0
enthalpy enthalpy 2 years ago
I bought more 4.04
👍️0
Gator44 Gator44 2 years ago
Couple of pennies are cloce enough
👍️0
the_stockoracle the_stockoracle 2 years ago
Learn your charts lol $3.93 is the gap fill
👍️0
Gator44 Gator44 2 years ago
Gap filled boys and girls...
Big boy buying today !!!
👍️0
peterus peterus 2 years ago
dont think we will see 3.50s
but it could happen with this market
👍️0
enthalpy enthalpy 2 years ago
Whats your thoughts on it hitting 3.50?
👍️0
the_stockoracle the_stockoracle 2 years ago
When it hits $3.93 tomorrow is where I’ll be buying my first order
👍️0
enthalpy enthalpy 2 years ago
Tomorrow we probably hit 3.75ish and that's close enough to the 62% fibonacci pullback. If it hits 3.75 rsi will be around mid 50s give or take which is good.
👍️0
enthalpy enthalpy 2 years ago
Probably right. I loaded some at 4.20 with rsi at 61 but i think 3.75 is the target. Glta.
👍️0
peterus peterus 2 years ago
beter on side line and buy bottom
👍️0

Your Recent History

NASDAQ
IFRX
InflaRx NV
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads